A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

NCT07193550 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Bone Sarcomas

Interventions

DRUG: Zanzalintinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]